BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37283736)

  • 1. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Plasma 25(OH)D
    Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela.
    Bahgat MM; Nadeem R; Nasraa MH; Amer K; Hassan WA; ELGarhy FM; Reda S; Abd-Elshafy DN
    Viral Immunol; 2023 Nov; 36(9):600-609. PubMed ID: 37831918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
    Jia F; Wang G; Xu J; Long J; Deng F; Jiang W
    Aging (Albany NY); 2021 Nov; 13(21):23895-23912. PubMed ID: 34725309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
    Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
    Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the inflammatory response to COVID-19 illness in pregnancy.
    Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM
    Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study.
    Tufa A; Gebremariam TH; Manyazewal T; Getinet T; Webb DL; Hellström PM; Genet S
    Front Immunol; 2022; 13():964179. PubMed ID: 35958594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival.
    Kumboyono K; Chomsy IN; Iskandar A; Aryati A; Parwati I; Wihastuti TA
    Infect Drug Resist; 2022; 15():821-829. PubMed ID: 35281571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of immunological biomarkers in COVID-19 and bacterial pneumonia.
    Abakar MAA; Hamad DHA; Faisal E; Omer HMF; Faki MTM; Idris AEM; Omer R; Osman Z; Elhassan EAG; Abrahim-Holie MA; Hakami MA; Alghamdi A; Alfahed A; Aloraini GS; Alharthi NS; Waggiallah HA
    J Med Life; 2023 Dec; 16(12):1844-1851. PubMed ID: 38585537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.
    Mansoor S; Butt AR; Bibi A; Mushtaq S; Ullah I; Alshahrani F; Khan A; Mansoor A
    PLoS One; 2023; 18(9):e0291332. PubMed ID: 37756264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
    Körper S; Schrezenmeier EV; Rincon-Arevalo H; Grüner B; Zickler D; Weiss M; Wiesmann T; Zacharowski K; Kalbhenn J; Bentz M; Dollinger MM; Paul G; Lepper PM; Ernst L; Wulf H; Zinn S; Appl T; Jahrsdörfer B; Rojewski M; Lotfi R; Dörner T; Jungwirth B; Seifried E; Fürst D; Schrezenmeier H
    Front Immunol; 2022; 13():1008438. PubMed ID: 36275695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.
    Merza MY; Hwaiz RA; Hamad BK; Mohammad KA; Hama HA; Karim AY
    PLoS One; 2021; 16(4):e0250330. PubMed ID: 33914789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Karaba AH; Zhou W; Hsieh LL; Figueroa A; Massaccesi G; Rothman RE; Fenstermacher KZJ; Sauer L; Shaw-Saliba K; Blair PW; Robinson ML; Leung S; Wesson R; Alachkar N; El-Diwany R; Ji H; Cox AL
    Clin Infect Dis; 2022 Jan; 74(2):254-262. PubMed ID: 34013339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
    Majeed AY; Zulkafli NES; Ad'hiah AH
    Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression.
    Mohamed HA; Abdelkafy AE; Khairy RMM; Abdelraheim SR; Kamel BA; Marey H
    Sci Rep; 2023 Mar; 13(1):3531. PubMed ID: 36864077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.